ES2157404T3 - Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2157404T3
ES2157404T3 ES96400052T ES96400052T ES2157404T3 ES 2157404 T3 ES2157404 T3 ES 2157404T3 ES 96400052 T ES96400052 T ES 96400052T ES 96400052 T ES96400052 T ES 96400052T ES 2157404 T3 ES2157404 T3 ES 2157404T3
Authority
ES
Spain
Prior art keywords
alkyl
substd
opt
new
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96400052T
Other languages
English (en)
Inventor
Daniel Lesieur
Eric Fourmaintraux
Patrick Depreux
Philippe Delagrange
Pierre Renard
Beatrice Guardiola-Lemaitre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2157404T3 publication Critical patent/ES2157404T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPUESTOS DE FORMULA (I) EN LA QUE: - R 1 REPRESENTA UN RADICAL ELEGIDO ENTRE ALQUILO, ALQUILO SUSTITUIDO, CICLOALQUILO, CICLOALQUILO SUSTITUIDO, CICLOALQUILALQUILO, Y CICLOALQUILALQUILO SUSTITUIDO, - A FORMA CON EL NUCLEO BENCENICO CON EL QUE ESTA FUSIONADO UN GRUPO CICLICO ELEGIDO ENTRE BENZOFURANO, 2,3DIHIDROBENZOFURANO - R{SUB,2} REPRESENTA UN HIDROGENO O UN ALQUILO, R{SUB,3} REPRESENTA: . UN GRUPO R{SUB,31}: CON X REPRESENTANDO UN AZUFRE O UN OXIGENO Y R4 REPRESENTANDO UN HIDROGENO O UN RADICAL R{SUB,41} ELEGIDO ENTRE ALQUILO, ALQUILO SUSTITUIDO, ALCENILO, ALCINILO, CICLOALQUILO, CICLOALQUILO SUSTITUIDO, CICLOALAQUILALQUILO Y CICLOALQUILALQUILO SUSTITUIDO, . O UN GRUPO DE FORMULA (R{SUB,32}): CON X'' REPRESENTANDO UN AZUFRE O UN OXIGENO Y R{SUB,5} REPRESENTANDO UN HIDROGENO O UN RADICAL ELEGIDO ENTRE ALQUILO, ALQUILO SUSTITUIDO, CICLOALQUILO, CICLOALQUILO SUSTITUIDO, CICLOALQUILALQUILO Y CICLOALQUIALQUILO SUSTITUIDO Y SU APLICACION COMO LIGANDOS DE LOS RECEPTORES MELATONINERGICOS.
ES96400052T 1995-01-11 1996-01-10 Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2157404T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500238A FR2729147A1 (fr) 1995-01-11 1995-01-11 Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2157404T3 true ES2157404T3 (es) 2001-08-16

Family

ID=9475014

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96400052T Expired - Lifetime ES2157404T3 (es) 1995-01-11 1996-01-10 Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES96400051T Expired - Lifetime ES2142550T3 (es) 1995-01-11 1996-01-10 Nuevos compuestos (hetero)ciclicos alquilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES96400051T Expired - Lifetime ES2142550T3 (es) 1995-01-11 1996-01-10 Nuevos compuestos (hetero)ciclicos alquilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Country Status (19)

Country Link
US (3) US5693665A (es)
EP (2) EP0721947B1 (es)
JP (2) JPH08239353A (es)
CN (2) CN1061653C (es)
AT (2) ATE199715T1 (es)
AU (2) AU714316B2 (es)
CA (2) CA2167040C (es)
CY (1) CY2174B1 (es)
DE (2) DE69612022T2 (es)
DK (2) DK0721938T3 (es)
ES (2) ES2157404T3 (es)
FI (2) FI960123A (es)
FR (1) FR2729147A1 (es)
GR (2) GR3032174T3 (es)
HK (1) HK1013284A1 (es)
NO (2) NO313552B1 (es)
NZ (2) NZ280805A (es)
PT (1) PT721947E (es)
ZA (2) ZA96212B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043264A (en) * 1995-01-06 2000-03-28 Toray Industries, Inc. Benzene-condensed heterocyclic derivatives and their uses
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
US5708005A (en) * 1995-06-27 1998-01-13 Takeda Chemical Industries, Ltd. Quinolines, their production and use
EP0848699B1 (en) * 1995-07-26 2001-10-24 Takeda Chemical Industries, Ltd. Benzocycloalkene compounds with melatonine receptor binding affinity, their production and use
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR100572900B1 (ko) * 1997-08-07 2006-04-24 후지모토 쿄다이 가부시키가이샤 에틸아민 유도체
FR2771739B1 (fr) * 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2772766B1 (fr) * 1997-12-24 2000-06-30 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2784375B1 (fr) * 1998-10-12 2000-11-24 Adir Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP4877679B2 (ja) * 1999-09-03 2012-02-15 雪印種苗株式会社 植物成長調整剤
US6822101B2 (en) 2002-09-16 2004-11-23 Abbott Laboratories Process for preparing amine-substituted benzofurans
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
FR2853649B1 (fr) * 2003-04-09 2006-07-14 Servier Lab Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7393865B2 (en) 2004-06-17 2008-07-01 Neurocrine Biosciences, Inc. Sleep inducing compounds and methods relating thereto
FR2942625B1 (fr) * 2009-03-02 2013-11-22 Centre Nat Rech Scient Derives indoliques pour le traitement de maladies neurodegeneratives
US11590663B2 (en) 2020-01-14 2023-02-28 International Business Machines Corporation Virtual reality enabled activity allocation
RU2750418C1 (ru) * 2020-11-20 2021-06-28 Виктор Владимирович Яснецов Средство, обладающее противогипоксической, антиамнестической и нейропротекторной активностью

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3226402A (en) * 1965-12-28 And process of making and using same
US3407210A (en) * 1961-11-03 1968-10-22 Byk Gulden Lomberg Chem Fab Aminoethyl-benzofurans and derivatives thereof
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680507B1 (fr) * 1991-08-23 1993-10-08 Adir Cie Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) * 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HK1013284A1 (en) 1999-08-20
EP0721947A1 (fr) 1996-07-17
FI960124A (fi) 1996-07-12
FI960123A (fi) 1996-07-12
CA2167039A1 (fr) 1996-07-12
DE69612022T2 (de) 2001-09-20
PT721947E (pt) 2001-08-30
NZ280805A (en) 1998-03-25
GR3035789T3 (en) 2001-07-31
CN1134938A (zh) 1996-11-06
FI960123A0 (fi) 1996-01-10
CN1067678C (zh) 2001-06-27
ZA96212B (en) 1996-07-26
CN1061653C (zh) 2001-02-07
NO960109L (no) 1996-07-12
FR2729147A1 (fr) 1996-07-12
NO313552B1 (no) 2002-10-21
FR2729147B1 (es) 1997-02-14
DK0721938T3 (da) 2000-05-29
DE69605452T2 (de) 2000-07-06
US5693665A (en) 1997-12-02
DE69605452D1 (de) 2000-01-13
EP0721938A1 (fr) 1996-07-17
EP0721947B1 (fr) 2001-03-14
NO960108L (no) 1996-07-12
NO960109D0 (no) 1996-01-10
AU4089496A (en) 1996-07-18
ZA96213B (en) 1996-07-26
AU4089396A (en) 1996-07-18
CA2167040C (fr) 2001-05-08
US5780512A (en) 1998-07-14
US5703121A (en) 1997-12-30
AU714316B2 (en) 1999-12-23
CA2167039C (fr) 2002-08-27
DE69612022D1 (de) 2001-04-19
NO960108D0 (no) 1996-01-10
NO312897B1 (no) 2002-07-15
JPH08231530A (ja) 1996-09-10
FI960124A0 (fi) 1996-01-10
GR3032174T3 (en) 2000-04-27
ES2142550T3 (es) 2000-04-16
CY2174B1 (en) 2002-08-23
DK0721947T3 (da) 2001-04-17
AU694588B2 (en) 1998-07-23
JPH08239353A (ja) 1996-09-17
CN1135480A (zh) 1996-11-13
ATE187438T1 (de) 1999-12-15
NZ280806A (en) 1996-09-25
CA2167040A1 (fr) 1996-07-12
JP3790289B2 (ja) 2006-06-28
ATE199715T1 (de) 2001-03-15
EP0721938B1 (fr) 1999-12-08

Similar Documents

Publication Publication Date Title
ES2157404T3 (es) Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69605856D1 (de) Alkoxyarylverbindungen mit Affinität zu den Melatoninrezeptoren, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
AR002041A1 (es) Nuevos taxoides, procedimiento para prepararlos, los compuestos intermediarios de aplicacion con dicho procedimiento, procedimiento parapreparar dichos intermediarios y las composiciones farmaceuticas que contienen dichos taxoides.
MX9305994A (es) Compuestos de n-aminoalquilcarboniloxialquilpirrol y composicioninsecticida que los contiene.
BG100887A (en) Process for the preparation of 7-hydroxy taxanes
AU1344995A (en) New substituted sulphonamides, a process for their preparation and pharmaceutical compositions containing them
DE69304011D1 (de) N-Substituierte Carbonyloxyalkylpyrrol enthaltende insekticide, acarizide und molluskizide Mittel
ES2119337T3 (es) Nuevas o-aril-metil-(tio)acil-hidroxil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69304010D1 (de) N-Oxo und Thioalkylcarbonyloxyalkyl Pyrrol enthaltende insektizide, acarizide und molluskizide Mittel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 721947

Country of ref document: ES